Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001493152-24-043649
Filing Date
2024-11-05
Accepted
2024-11-05 15:10:41
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc13da.htm SC 13D/A 51508
  Complete submission text file 0001493152-24-043649.txt   53387
Mailing Address 280 SOUTH BEVERLY DR. SUITE 505 BEVERLY HILLS CA 90212
Business Address 280 SOUTH BEVERLY DR. SUITE 505 BEVERLY HILLS CA 90212 508-523-3141
Nordicus Partners Corp (Subject) CIK: 0001011060 (see all company filings)

EIN.: 043186647 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-48655 | Film No.: 241427145
SIC: 8742 Services-Management Consulting Services
(CF Office: 07 Trade & Services)

Mailing Address MESTERLODDEN 3A, 1. GENTOFTE G7 2820
Business Address MESTERLODDEN 3A, 1. GENTOFTE G7 2820 4553842743
Alteral Therapeutics ApS (Filed by) CIK: 0002026040 (see all company filings)

EIN.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: SC 13D/A